Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer

A new approach for using extracellular vesicles (EVs) to deliver tyrosine kinase inhibitors (TKIs) to enhance iodine avidity in radioactive iodine-refractory thyroid cancer is needed. We isolated and characterized primary human adipose-derived stem cells (ADSCs) and isolated their EVs. The EVs were...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutics
Main Authors: Rajendran, Ramya Lakshmi, Paudel, Sanjita, Gangadaran, Prakash, Oh, Ji Min, Oh, Eun Jung, Hong, Chae Moon, Lee, Sangkyu, Chung, Ho Yun, Lee, Jaetae, Ahn, Byeong-Cheol
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7916551/
https://ncbi.nlm.nih.gov/pubmed/33578882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13020248
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items